BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2019
View Archived Issues
IDEAYA Biosciences initiates phase I/II study of IDE-196
Read More
A novel androgen receptor antagonist is a promising candidate for enzalutamide-resistant CRPC
Read More
BR-11257, a novel nonstabilizing soluble guanylyl cyclase partial agonist
Read More
AptaTargets initiates first-in-human trial of ApTOLL
Read More
Bayer initiates phase II AVANTI study of BAY-1753011 in congestive heart failure
Read More
ImmusanT discontinues phase II study of Nexvax2 in celiac disease
Read More
MolMed suspends enrollment of new patients in phase III TK008 study of Zalmoxis
Read More
Phase II results presented for pazopanib in patients with progressive carcinoid tumors
Read More
Notch1 as a promising new therapeutic target in multiple myeloma
Read More
[18F]Afatinib PET/CT as promising new tool for selecting patients with NSCLC for afatinib therapy
Read More
Addressing glioblastoma by targeting LDLR with VH-DO-33 radioisotopes
Read More
Amino acid derivative may be schizophrenia treatment
Read More
Cryptic sensitivity can be unmasked in MRSA
Read More
EBV's metabolic transformation
Read More
Enanta Pharmaceuticals patents anti-HBV agents
Read More
Rockefeller University presents kappa-opioid receptor agonists
Read More
GlaxoSmithKline identifies mTOR inhibitors
Read More
Roche describes MGL inhibitors
Read More
Leo Pharma divulges PDE4 and TNF-alpha release inhibitors
Read More
Identification of atrovimycin, a novel antitubercular and antifungal cyclodepsipeptide
Read More
ADC Therapeutics presents phase I data for loncastuximab tesirine in R/R DLBCL
Read More
Guerbet begins phase III study of contrast agent gadopiclenol for CNS imaging
Read More
Vedanta's live biotherapeutic product candidate VE-416 begins phase Ib/II study for peanut allergy
Read More
Phase III study of sildenafil in newborns with PPHN does not meet primary efficacy endpoint
Read More
Oxurion reports phase I topline data on THR-149 in DME
Read More
Danish Medicines Agency approves AJ Vaccines' polio vaccine
Read More